Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

SHE:300636 Revenue

Jiangxi Synergy Pharmaceutical had revenue of 225.05M CNY in the quarter ending September 30, 2026, with 7.77% growth. This brings the company's total for the last twelve months to 800.64M, down -2.98% year-over-year. In the year 2025, Jiangxi Synergy Pharmaceutical had annual revenue of 828.66M with 9.19% growth. That makes Jiangxi Synergy Pharmaceutical the 21,333rd largest company in the world by revenue and 3,918th in China.

• Revenue (ttm): 800.64M
• Revenue Growth: -2.98%
• P/S Ratio: 3.41
• Revenue / Employee: 493.31K
• Employees: 1,623
• Market Cap: 2.73B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing 825.05M 99.6%
• Unallocated Other Operations 3.61M 0.4%

By Geography

Chart

• Foreign 668.94M 80.7%
• China 159.72M 19.3%

Fiscal year ended Dec 31, 2025 See the full SHE:300636 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	828.66M	69.77M	9.19%
Dec 31, 2024	758.89M	36.75M	5.09%
Dec 31, 2023	722.14M	2.23M	0.31%
Jan 1, 2023	719.91M	127.78M	21.58%
Dec 31, 2021	592.13M	156.71M	35.99%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error